Preventive antibiotics for stroke-associated pneumonia

Pneumonia impedes recovery from acute stroke and contributes to poor clinical outcomes. Two recent clinical trials demonstrate that antibiotics commonly used to treat stroke-associated pneumonia (SAP) neither reduce the frequency of pneumonia nor improve outcome after stroke when administered in a preventive manner. These findings necessitate fundamental reassessment of our current concepts of SAP.